BiotechTube
Home/Ridgeline Therapeutics/Harshini Neelakantan, PhD
HN

Harshini Neelakantan, PhD

Exec. Director, Research & Development

Ridgeline Therapeutics

Therapeutic Areas

Metabolic DiseasesMusculoskeletal DisordersRenal Disease

Ridgeline Therapeutics Pipeline

DrugIndicationPhase
NNMT Inhibitor ProgramSarcopenia/Frailty, Type 2 Diabetes, Obesity, Muscular Dystrophies, Kidney DiseasePreclinical

Leadership Team at Ridgeline Therapeutics

SW
Stan Watowich, PhD
Founder & CEO
ST
Suzanne Tomlinson, PhD, MBA
Director, Finance & Operations
View full Ridgeline Therapeutics profile